Bapotulimab

Tax included
Bapotulimab (BAY-1905254) is a fully human IgG2 antibody targeting immunoglobulin-like domain containing receptor 2 (ILDR2). Bapotulimab has antitumor and immunosuppressive effects.
HY-P99460

Data sheet

Size
Multiple sizes
Reactivity
Others
CAS
2359413-58-2